top
Search terms
Results 171 - 178 of 178 - ordered by :
Pages: 1 ... 12 13 14 15 16 17 18
Ehjournal

Helmut Baumgartner MD, FACC, FESC, chair of the taskforce for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic ...

European Heart Journal, Ozkan, Judith

Date : 21/09/2017 Item size : 111080 bytes
Ehjournal

Hypertrophic cardiomyopathy (HCM) is among the most common inherited forms of cardiomyopathy, with estimated prevalence of at least 1 in 500 people, affecting males and females equally given ...

European Heart Journal, Owens, Anjali Tiku

Date : 14/09/2017 Item size : 163336 bytes
Ehjournal

Up to 80% of these patients develop pulmonary hypertension (PH), which is associated with worse symptoms and increased mortality.1 It is a matter of concern that drugs approved for pulmonary arterial ...

European Heart Journal, Hoeper, Marius M, Lam, Carolyn S P, Vachiery, Jean-Luc, Bauersachs, Johann, Gerges, Christian, Lang, Irene M, Bonderman, Diana, Olsson, Karen M, Gibbs, J Simon R, Dorfmuller, ...

Date : 07/10/2017 Item size : 316148 bytes
Ehjournal

Pulmonary hypertension (PH) is common and contributes to increased morbidity and mortality in people with heart failure (HF) with preserved ejection fraction (HFpEF).1 Pulmonary hypertension in HFpEF ...

European Heart Journal, Borlaug, Barry A, Obokata, Masaru

Date : 07/10/2017 Item size : 269587 bytes
Ehjournal

Frontiers in congenital heart disease: pulmonary hypertension, heart failure, and arrhythmias Download the Issue @ a Glance podcast Subscribe to the EHJ Podcast Although rare and affecting 0.8% of ...

European Heart Journal, Lüscher, Thomas F.

Date : 07/05/2016 Item size : 224551 bytes
Ehjournal

Significant changes and adaptations have been recommended, when compared with the previous version of the ESC/ERS pulmonary hypertension guidelines published in 2009.3,4 The table of contents ...

European Heart Journal

Date : 01/01/2016 Item size : 159611 bytes
Ehjournal

The authors concluded that phosphodiesterase 5 inhibitors (PDE5i) can be harmful in such patients, something the accompanying editorial emphasized.2 Pulmonary vasodilators improve outcomes by ...

European Heart Journal, Al Maluli, Hayan

Date : 21/09/2018 Item size : 116764 bytes
Ehjournal

The authors concluded that phosphodiesterase 5 inhibitors (PDE5i) can be harmful in such patients, something the accompanying editorial emphasized.2 Pulmonary vasodilators improve outcomes by ...

European Heart Journal, Al Maluli, Hayan

Date : 21/09/2018 Item size : 111711 bytes